Dyslipidemia in primary care - prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS)

Steinhagen-Thiessen, Elisabeth; Bramlage, Peter; L�sch, Christian; Hauner, Hans; Schunkert, Heribert; Vogt, Anja; Wasem, J�rgen; J�ckel, Karl-Heinz; Moebus, Susanne
January 2008
Cardiovascular Diabetology;2008, Vol. 7, p1
Academic Journal
Background: Current guidelines from the European Society of Cardiology (ESC) define low thresholds for the diagnosis of dyslipidemia using total cholesterol (TC) and LDL-cholesterol (LDL-C) to guide treatment. Although being mainly a prevention tool, its thresholds are difficult to meet in clinical practice, especially primary care. Methods: In a nationwide study with 1,511 primary care physicians and 35,869 patients we determined the prevalence of dyslipidemia, its recognition, treatment, and control rates. Diagnosis of dyslipidemia was based on TC and LDL-C. Basic descriptive statistics and prevalence rate ratios, as well as 95% confidence intervals were calculated. Results: Dyslipidemia was highly frequent in primary care (76% overall). 48.6% of male and 39.9% of female patients with dyslipidemia was diagnosed by the physicians. Life style intervention did however control dyslipidemia in about 10% of patients only. A higher proportion (34.1% of male and 26.7% female) was controlled when receiving pharmacotherapy. The chance to be diagnosed and subsequently controlled using pharmacotherapy was higher in male (PRR 1.15; 95%CI 1.12-1.17), in patients with concomitant cardiovascular risk factors, in patients with hypertension (PRR 1.20; 95%CI 1.05-1.37) and cardiovascular disease (PRR 1.46; 95%CI 1.29-1.64), previous myocardial infarction (PRR 1.32; 95%CI 1.19-1.47), and if patients knew to be hypertensive (PRR 1.18; 95%CI 1.04-1.34) or knew about their prior myocardial infarction (PRR 1.17; 95%CI 1.23-1.53). Conclusion: Thresholds of the ESC seem to be difficult to meet. A simple call for more aggressive treatment or higher patient compliance is apparently not enough to enhance the proportion of controlled patients. A shift towards a multifactorial treatment considering lifestyle interventions and pharmacotherapy to reduce weight and lipids may be the only way in a population where just to be normal is certainly not ideal.


Related Articles

  • Education: Viewpoint - Screening athletes for SCD.  // GP: General Practitioner;11/7/2012, p51 

    The article offers information on aetiology, epidemiology, role of primary care in screening and international screening strategies. Guidelines from the European Society of Cardiology mandate the application of 12-lead electrocardiography (ECG). General practitioners (GPs) can play a significant...

  • MHRA issues warning on the use of aspirin.  // Independent Nurse;10/19/2009, p12 

    The article reports on the warning from the Medicines and Healthcare Product Regulatory Agency (MHRA) that aspirin is not licensed for primary prevention of vascular disease. The drug safety update released by the MHRA is supported by studies which found that the benefits of aspirin in primary...

  • Reducing Global Risk of Ambulatory Assisted Hypertensive Patients - What Could Be Changed in the Practice of a Romanian Preventive Ambulatory System According to New Dyslipidaemia Guidelines? Preg, Z.; Kikeli, P.; Márta, Germán-Salló; Mihaela, Hubatsch; Andreea-Elena, Bocicor; László, M. I. // Acta Medica Marisiensis;2012, Vol. 58 Issue 4, p251 

    Reducing the total cardiovascular risk of hypertensive patients is one of the basic targets in hypertension management. A good lipid control is a major contributor of the global risk reduction. Purpose: To simulate the impact of the ESC/EAS 2011 guidelines for the management of dyslipidaemias on...

  • Investigation the Prevalence of Bacteremia after Coronary Artery Intervention in Patients Refereed to Afshar Hospital in Yazd, Iran. mahmoud, Emami; Masoud, Mirzaei; Azadeh, Meybodi // Middle East Journal of Scientific Research;2013, Vol. 14 Issue 5, p662 

    Percutaneus coronary artery intervention (PCI) is increasing in patients with cardiovascular disease. In this intervention some instruments enter into the vessels and it makes PCI as a risk factor for bacteremia and sepsis. bacteremia is rare, but is able to increase mortality rate. This study...

  • Where are the primary care physicians?  // H&HN: Hospitals & Health Networks;1/20/94, Vol. 68 Issue 2, p16 

    Reports on the distribution of primary care physicians in the United States. Physicians included in the group; Problem of low numbers of primary care physicians in certain states; States with the fewest primary care physicians; States with the highest concentrations of primary care physicians;...

  • Collecting morbidity data in general practice: The Somerset morbidity project. Pearson, Nicky; O'Brien, Jim // BMJ: British Medical Journal (International Edition);06/15/96, Vol. 312 Issue 7045, p1517 

    Focuses on a representative database of morbidity presenting to primary care in Somerset, England and the use of data to help commission services on the basis of local need and effectiveness. Feasibility of establishing a network of practices recording and reporting morbidity seen in primary...

  • Spiritual Assessment in Primary Care. Unger, Jeff // Internal Medicine Alert;10/15/2012, Vol. 34 Issue 19, p148 

    Evidence-based spiritual assessment tools are presented in this manuscript, which open a dialogue between patients and physicians. These adjunctive therapeutic interventions have been found to improve outcomes for patients with depression, cardiovascular disease, pain, anxiety, and adolescent...

  • Inhibition of Microsomal Triglyceride Transfer Protein in Familial Hypercholesterolemia. Cuchel, Marina; Bloedon, LeAnne T.; Szapary, Philippe O.; Kolansky, Daniel M.; Wolfe, Megan L.; Sarkis, Antoine; Millar, John S.; Ikewaki, Katsunori; Siegelman, Evan S.; Gregg, Richard E.; Rader, Daniel J. // New England Journal of Medicine;1/11/2007, Vol. 356 Issue 2, p148 

    Background: Patients with homozygous familial hypercholesterolemia have markedly elevated cholesterol levels, which respond poorly to drug therapy, and a very high risk of premature cardiovascular disease. Inhibition of the microsomal triglyceride transfer protein may be effective in reducing...

  • Pharmacologic Lipid-Lowering Therapy in Type 2 Diabetes Mellitus: Background Paper for the American College of Physicians. Vijan, Sandeep; Hayward, Rodney A. // Annals of Internal Medicine;4/20/2004, Vol. 140 Issue 8, p650 

    Background: Cardiovascular disease is the primary complication and cause of death in patients with type 2 diabetes mellitus. Modification of cardiovascular risk factors may improve patient outcomes. Purpose: To evaluate the effectiveness of pharmacologic lipid-lowering therapy on outcomes...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics